- Revenue: Total revenue was $279 million, up 11% year-over-year, marking the third consecutive quarter of double-digit sales growth.
- Industrial Solutions Revenue: Increased 16% year-over-year, driven by growth in welding, marking, cleaning, and additive manufacturing.
- Advanced Solutions Revenue: Decreased 9% year-over-year but improved 10% sequentially, with growth in semiconductor applications.
- GAAP Gross Margin: 40.4%.
- Adjusted Gross Margin: 40.7%, above the top end of guidance, benefiting from a $4.7 million tariff refund (approximately 170 basis points).
- Adjusted Operating Expenses: $91 million, excluding $17.6 million in impairment charges and other one-time items.
- GAAP Operating Income: $5 million.
- GAAP Net Income: $5 million, or $0.12 per diluted share.
- Adjusted Operating Income: $24 million.
- Adjusted Net Income: $25 million.
- Adjusted EPS: $0.58 per diluted share, above the top end of guidance.
- Adjusted EBITDA: $49 million.
- Cash and Investments: $871 million in cash, cash equivalents, and short-term investments, with no debt.
- Cash Flow from Operations: $38 million in the quarter.
- Capital Expenditures: $21 million in the quarter; year-to-date CapEx of $37 million.
- Emerging Growth Products Sales: Accounted for 58% of total revenue, up from 53% in the prior quarter.
- Regional Revenue: North America decreased 2% year-over-year; Europe increased 5%; Asia increased 19%.
- Book-to-Bill: Remained above one.
- Third Quarter 2026 Guidance: Revenue expected between $265 million and $295 million; adjusted gross margin between 37.5% and 40.5%; adjusted EPS between $0.30 and $0.60; adjusted EBITDA between $35 million and $51 million.
Release Date: August 04, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
- IPG Photonics Corp IPGP reported double-digit year-over-year revenue growth for the third consecutive quarter, with Q2 revenue reaching $279 million, up 11%.
- Bookings remained strong with book-to-bill above 1 for the third consecutive quarter, indicating sustained demand.
- Adjusted gross margin and adjusted EPS exceeded expectations, with adjusted EPS at $0.58 and adjusted EBITDA at $49 million.
- The company is making significant progress in strategic growth areas, including battery manufacturing, additive manufacturing, and semiconductor applications, with emerging growth products now accounting for 58% of total revenue.
- IPG Photonics Corp (IPGP) announced a binding offer to acquire Lumibird Medical, which is expected to expand its medical laser platform, be accretive to margins and EPS in the first year, and increase its addressable medical market by approximately $1 billion.
- The company is seeing strong demand and positive momentum for its CROSSBOW directed energy defense system, having begun shipping Lockheed Martin's order and demonstrating capabilities in harsh conditions.
Negative Points
- Advanced Solutions revenue decreased 9% year-over-year, driven by lower revenue in micromachining and defense.
- North American revenue declined 2% year-over-year due to lower sales in cutting, defense, and medical applications.
- The company faces ongoing headwinds from tariffs, which are expected to impact gross margin by approximately 150 basis points in Q3 2026.
- Manufacturing cost absorption remains below target levels, limiting gross margin expansion.
- Europe continues to be impacted by higher oil prices and geopolitical tensions, affecting demand in that region.
- The company expects operating expenses to modestly increase going forward due to continued investments in growth initiatives.
Q & A Highlights
Q: Ruben Roy (Stifel) asked about the sustainability of the strong bookings trend (book-to-bill above 1 for three consecutive quarters) and how the company is building a shippable backlog against the Q3 revenue guidance, which is roughly flat at the midpoint.
A: Mark Gitin (CEO) confirmed the company is seeing double-digit year-over-year growth for the third consecutive quarter, with book-to-bill above one again. He highlighted encouraging signs across the business, particularly in industrial solutions (battery, additive manufacturing, cleaning) and noted that global PMIs have been expansive and stable, providing positive momentum for advanced solutions.
Q: Ruben Roy (Stifel) followed up on the battery commentary, asking about the durability of demand in welding and battery manufacturing, and specifically about IPG's performance in China, including market share gains and the pricing environment.
A: Mark Gitin (CEO) explained that demand is driven by high-capacity batteries for EVs and, increasingly, stationary storage for data centers and grid stability. In China, IPG is winning design wins against both local and Western competitors due to differentiation from its Adjustable Mode Beam (AMB) lasers, beam delivery, and measurement capabilities. He noted the company has pricing power in areas of strong differentiation and highlighted growth in additive manufacturing, where new lasers improve throughput by 1.5 to 2 times, expanding the market into medical and consumer devices.
Q: Ruben Roy (Stifel) asked CFO Tim Mammen about the progress on structural cost-out initiatives and how he is thinking about utilization leverage and gross margins going forward.
A: Timothy Mammen (CFO) detailed several drivers for gross margin improvement: taking cost out of products by moving to higher-power optical components (like diodes), optimizing pricing where IPG has differentiation, and driving improvements in manufacturing absorption. He stated that while the company is still behind on absorption targets, initiatives gaining momentum in the second half of 2026 and into 2027 should drive continued gross margin improvements.
Q: Jim Ricchiuti (Needham) asked about the decline in North America revenue, specifically the softer medical business, and what the expectations are for that segment going forward, apart from the Lumibird acquisition.
A: Mark Gitin (CEO) stated that medical demand and backlog are very strong, and the company is confident in another good year. He cited new product approvals and introductions planned for 2026 and 2027, a key new product launched at the end of last year, and a new key customer. He reiterated confidence in more than doubling the medical business over the next two to three years.
Q: Jim Ricchiuti (Needham) asked about the tone of demand for the rest of the North American business and whether expectations for CROSSBOW in 2027 have changed.
A: Mark Gitin (CEO) noted that overall bookings are strong with a book-to-bill above one for the third consecutive quarter, with strength in Asia (Japan and China) and improvement in Europe. On CROSSBOW, he expressed excitement about the program, citing daily headlines on drone threats and the system's compelling cost-exchange ratio. He highlighted recent successful tests at White Sands Missile Range with multiple agencies, including extreme environmental conditions and cooperative engagement tactics, and remains optimistic about both military and civilian applications.
Q: Jim Ricchiuti (Needham) asked if the book-to-bill ratio was consistent across major regions or if there was any variability.
A: Timothy Mammen (CFO) said there wasn't much variability, with good bookings in Asia (Japan and China), North America, and Europe. He noted Europe is the area most impacted by higher oil prices and the geopolitical environment. He also mentioned strong medical bookings and progress in advanced applications like semiconductor and micromachining, which are still small but gaining a beachhead.
Q: Scott Graham (Seaport Research) asked about the company's efforts to get customers to upgrade lasers and change out machinery, citing the 1.5 to 2 times efficiency gain in additive manufacturing.
A: Mark Gitin (CEO) explained that IPG's unique strength lies in combining laser/photonics strength with deep application understanding. In additive, this led to specialized mode structures that improved throughput. In semiconductor, the company works with customers on roadmaps to develop specialized solutions for lithography, metrology, and inspection, getting designed into their systems. He also highlighted the subsystems business, where IPG provides full solutions including beam delivery and scanning capabilities.
Q: Scott Graham (Seaport Research) asked about the pricing environment, specifically whether recent price increases are intended to fully offset inflation or just partially.
A: Mark Gitin (CEO) said pricing power exists where IPG has strong differentiation and adds the most value. Timothy Mammen (CFO) added that the goal is to offset inflationary pressures on material and labor costs while also staying ahead of the curve by reducing product costs through higher-power components and improved manufacturing efficiency, leading to overall gross margin improvement.
Q: Keith Housum (Northcoast Research) asked about the size of the Adjustable Mode Beam (AMB) business and whether it is growing faster than the overall business.
A: Mark Gitin (CEO) confirmed that AMB lasers are a key piece of the battery welding growth, driven by stationary storage for data centers and longer-range EVs. He noted the high differentiation of the product, particularly the high-power single-mode beam, and highlighted that it is a significant driver of the emerging growth products, which accounted for 58% of total revenue in Q2, up from 53% in the prior quarter.
Q: Keith Housum (Northcoast Research) asked to confirm the size of the medical business, given the goal to double it in two to three years.
A: Mark Gitin (CEO) confirmed that medical is in the 7% to 8% range of total revenue.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
